|
| |
neogenesis pharmaceuticals patent Pages on BioPortfolio:
BioPortfolio - NeoGenesis
NeoGenesis Pharmaceuticals, 840 Memorial Drive, Cambridge, Massachusetts, J Comb Chem. 2005 Jan-Feb;7(1):96-8. ... NeoGenesis Patents:. US Patent No. Title ...
http://www.bioportfolio.com/biocorporate/7431-NeoGenesis.htm...
|
BioPortfolio.com - BioWeb Neurogenic Bladder Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, ... is the patent protected BladderScanTM - an instrument that noninvasively ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - Waratah Pharmaceuticals
Waratah Pharmaceuticals Patents:. US Patent No. Title ... 6992060, Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand
...
http://www.bioportfolio.com/biocorporate/10946-Waratah_Pharm...
|
Biotechnology and Pharmaceutical Industry Search Find Companies ...
Company receives patent for I-MUNE Assay - Patents ... Neurogenic mechanisms in bronchial inflammatory diseases reviewed - Allergy Medicine ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Neurogenic Bladder patents
Neurogenic Bladder patents - BioPortfolio - Indepth. ... BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery
Disease ...
http://www.bioportfolio.com/indepth/Neurogenic_Bladder/paten...
|
BioPortfolio - xebec systems
litholink | biomedical systems | reko pharmaceutical | ichthyol | NeoGenesis download | t | jobs in ami, ibaraki | www.labcon.com | t | dr. paul chasen . ...
http://www.bioportfolio.com/search/xebec_systems.html...
|
BioPortfolio - Neurogenic Inflammation
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... Neurogenic Inflammation Patents:. USPTO Logo. US Patent No. Title ...
http://www.bioportfolio.com/indepth/Neurogenic_Inflammation....
|
BioPortfolio - Reconstructive Surgical Procedures
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery ... We report a 24-year-old patient with neurogenic bladder due to.
...
http://www.bioportfolio.com/indepth/Reconstructive_Surgical_...
|
BioPortfolio - Spinal Cord Injuries
[Survey of acupuncture treatment for neurogenic bladder dysfunction after spinal cord ... Pharma Live: Oct 8 2008 8:38PM Matching: spinal cord injuries ...
http://www.bioportfolio.com/indepth/Spinal_Cord_Injuries.htm...
|
BioPortfolio - Autonomic Dysreflexia
Data From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Prese, Pharma Live: Oct 29 2008 12:10PM Matching:
...
http://www.bioportfolio.com/indepth/Autonomic_Dysreflexia.ht...
|
Results from other life science and pharmaceutical sites:
{1} Announces Major Breakthrough In Drug Discovery Technology ...
But this new, patent-pending approach has revolutionized the capabilities of ... NeoGenesis Pharmaceuticals, Inc. is a drug discovery company which uses its ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1805772...
|
BioPortfolio - NeoGenesis
NeoGenesis Pharmaceuticals, 840 Memorial Drive, Cambridge, Massachusetts, J Comb Chem. 2005 Jan-Feb;7(1):96-8. ... NeoGenesis Patents:. US Patent No. Title ...
http://www.bioportfolio.com/biocorporate/7431-NeoGenesis.htm...
|
Buchwald Group - Alumni 1992-1995
NeoGenesis Pharmaceuticals, Inc., Cambridge, Massachusetts. Nov-03. Dr. Mary Beth Carter, Patent Agent Deciphera Pharmaceuticals, Lawrence, KS ...
http://mit.edu/chemistry/buchwald/people/alumni/alum1992-199...
|
Patent news Peter Steele
specifically, and for each there are two patent applications, ... Synt:em, Cubist Pharmaceuticals Inc and NeoGenesis Drug ...
http://www.biomedcentral.com/content/pdf/cd-471824.pdf...
|
Table 1 : Patent Watch : Nature Reviews Drug Discovery
EP 1810689, Mitsubishi Pharma, Deascribes a compound that suppresses FXR ... by suppressing hepatic glucose neogenesis or activating energy metabolism. ...
http://www.nature.com/nrd/journal/v7/n8/fig_tab/nrd2651_T1.h...
|
Patent News Peter Steele
Pharmaceuticals Inc was employed. Since the name Trega. was adopted, in April 1997, the company's level of. international patent activity seems to have ...
http://www.biomedcentral.com/content/pdf/cd-470257.pdf...
|
BioPortfolio - Waratah Pharmaceuticals
Waratah Pharmaceuticals Patents:. US Patent No. Title ... 6992060, Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand
...
http://www.bioportfolio.com/biocorporate/10946-Waratah_Pharm...
|
Patent selection
neogenesis therapy is a technology being developed by. Transition Therapeutics, who acquired Waratah Pharma in. 2002. See WO-02055152. ...
http://www.biomedcentral.com/content/pdf/cd-523814.pdf...
|
BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
... Recruitment Campaign for Neurogenic Overactive Bladder Study 7/19/2007 More. ... Dynogen Pharmaceuticals, Inc. Awarded U.S. Patent For Use Of DDP225 In ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...
|
Patent Alert
efflux pump inhibitor, to modulate neurogenic carboxy- ... as Revaax Pharmaceuticals LLC (a previously hardly-known. company from Indianapolis)
points out, ...
http://www.biomedcentral.com/content/pdf/cd-412421.pdf...
|
|
